Cuñarro-López Yolanda, Pintado-Recarte Pilar, Hernández-Martín Concepción, Paya-Martínez Pilar, López-Pérez Rocío, Cueto-Hernández Ignacio, Ruiz-Labarta Javier, Cano-Valderrama Óscar, Martínez-Pérez Óscar, Bravo-Arribas Coral, Ortega Miguel A, De León-Luis Juan Antonio
Department of Public and Maternal and Child Health, School of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
Department of Obstetrics and Gynecology, University Hospital Gregorio Marañón, 28009 Madrid, Spain.
J Pers Med. 2021 Jun 25;11(7):599. doi: 10.3390/jpm11070599.
During 2020, Coronavirus Disease-19 (COVID-19) incidence fluctuated in two clear waves across the spring and autumn periods. This study was designed to compare the maternal and perinatal clinical outcomes in obstetrics patients with COVID-19 between the two waves of infection in Spain. We conducted an observational, analytical, ambispective cohort study with longitudinal follow-up of mothers with confirmed SARV-CoV-2 infection from different hospitals in our country between March-November 2020. We recruited 1295 pregnant women with SARS-CoV2 infection from 78 hospitals, 846 (65.3%) of whom were diagnosed during the first wave and 449 (34.7%) during the second wave. Our results show that patients developing COVID-19 during the first wave had more symptoms at triage, early in pregnancy with greater rates of COVID-19-related maternal morbidity; caesarean section and preterm birth in the first wave. We register two cases of maternal mortality and only during the first wave. Maternal morbidity events showed a strong link to perinatal mortality events in the first wave compared to the second wave, in which maternal morbidity was more associated with pneumonia. Likewise, maternal morbidity showed a strong correlation with perinatal morbidity events in both waves. We describe the differences between the patients' profiles and management between the two waves and related to maternal and perinatal outcomes. Differences were also observed in the management of pregnant women with COVID-19. Thus, there were fewer caesarean sections, and maternal and perinatal morbidity events were reduced in the second wave, while the impacts of respiratory symptoms and their severity, including a greater need for maternal treatment, were greater in this last period. Identifying the impact that changes in the profile as well as in the treatment have on maternal-perinatal morbidity and mortality will help improve the well-being of our patients and their newborns.
2020年期间,新型冠状病毒肺炎(COVID-19)发病率在春秋两季出现了明显的两波波动。本研究旨在比较西班牙两波COVID-19感染期间产科COVID-19患者的孕产妇和围产期临床结局。我们进行了一项观察性、分析性、双向队列研究,对2020年3月至11月期间我国不同医院确诊感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的母亲进行纵向随访。我们从78家医院招募了1295名感染SARS-CoV-2的孕妇,其中846名(65.3%)在第一波感染期间被诊断出来,449名(34.7%)在第二波感染期间被诊断出来。我们的结果表明,在第一波感染期间感染COVID-19的患者在分诊时症状更多,怀孕早期COVID-19相关孕产妇发病率更高;第一波感染期间剖宫产和早产的发生率更高。我们记录了两例孕产妇死亡病例,且均仅发生在第一波感染期间。与第二波感染相比,第一波感染期间孕产妇发病事件与围产期死亡事件有很强的关联,在第二波感染中,孕产妇发病更多与肺炎相关。同样,两波感染中孕产妇发病与围产期发病事件均有很强的相关性。我们描述了两波感染期间患者特征和管理的差异以及与孕产妇和围产期结局的关系。在COVID-19孕妇的管理方面也观察到了差异。因此,第二波感染期间剖宫产较少,孕产妇和围产期发病事件减少,而在最后一个时期,呼吸道症状及其严重程度的影响更大,包括对孕产妇治疗的需求更大。确定患者特征和治疗变化对孕产妇-围产期发病率和死亡率的影响将有助于改善我们患者及其新生儿的健康状况。